1. Home
  2. EPIX vs NMS Comparison

EPIX vs NMS Comparison

Compare EPIX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • NMS
  • Stock Information
  • Founded
  • EPIX 2009
  • NMS 1993
  • Country
  • EPIX Canada
  • NMS United States
  • Employees
  • EPIX N/A
  • NMS N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • NMS Finance Companies
  • Sector
  • EPIX Health Care
  • NMS Finance
  • Exchange
  • EPIX Nasdaq
  • NMS Nasdaq
  • Market Cap
  • EPIX 75.9M
  • NMS 66.4M
  • IPO Year
  • EPIX N/A
  • NMS N/A
  • Fundamental
  • Price
  • EPIX N/A
  • NMS $11.33
  • Analyst Decision
  • EPIX Hold
  • NMS
  • Analyst Count
  • EPIX 3
  • NMS 0
  • Target Price
  • EPIX $2.00
  • NMS N/A
  • AVG Volume (30 Days)
  • EPIX 57.6K
  • NMS 12.0K
  • Earning Date
  • EPIX 08-04-2025
  • NMS 01-01-0001
  • Dividend Yield
  • EPIX N/A
  • NMS 4.11%
  • EPS Growth
  • EPIX N/A
  • NMS N/A
  • EPS
  • EPIX N/A
  • NMS N/A
  • Revenue
  • EPIX N/A
  • NMS N/A
  • Revenue This Year
  • EPIX N/A
  • NMS N/A
  • Revenue Next Year
  • EPIX N/A
  • NMS N/A
  • P/E Ratio
  • EPIX N/A
  • NMS N/A
  • Revenue Growth
  • EPIX N/A
  • NMS N/A
  • 52 Week Low
  • EPIX $1.40
  • NMS $9.21
  • 52 Week High
  • EPIX $7.88
  • NMS $12.18
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 50.49
  • NMS 51.44
  • Support Level
  • EPIX $1.67
  • NMS $11.31
  • Resistance Level
  • EPIX $1.73
  • NMS $11.43
  • Average True Range (ATR)
  • EPIX 0.04
  • NMS 0.08
  • MACD
  • EPIX -0.00
  • NMS 0.02
  • Stochastic Oscillator
  • EPIX 55.56
  • NMS 72.73

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About NMS Nuveen Minnesota Quality Municipal Income Fund

Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.

Share on Social Networks: